3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Ovarian Neoplasms
2
Colorectal Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Neoplasms
1
Metastatic Pancreatic Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Head and Neck Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Fallopian Tube Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Pancreatic Cancer
1
Interventions
lutetium Lu 177 dotatate
2
pembrolizumab
1
pasireotide
1
lanreotide
1
folfirinox
1
copper dotatate CU-64
1
arginyllysine
1
Receptor-Like Protein Tyrosine Phosphatases, Class 2
1
Octreotide
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cytokines
1
Cryotherapy
1
Carboplatin
1
Acupuncture Therapy
1
Acupressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastro-enteropancreatic neuroendocrine tumor
×
irinotecan sucrosofate
×
Clear all
No trials found.